Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4873342 | 0.97 | SMN1; SMN2 (0.33) | SMN1; SMN2FDPS | |
| SCHEMBL13024053 | 0.84 | FDPS (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL14008530 | 0.84 | FDPS (0.35) | SMN1; SMN2FDPS | |
| SCHEMBL4873469 | 0.80 | SMN1; SMN2 (0.32) | SMN1; SMN2FDPS | |
| SCHEMBL13066092 | 0.77 | SMN1; SMN2 (0.37) | SMN1; SMN2FDPS | |
| SCHEMBL24264704 | 0.74 | SMN1; SMN2 (0.38) | SMN1; SMN2FDPSMEN1KMT2ACHRNB2 | |
| SCHEMBL7047202 | 0.74 | SMN1; SMN2 (0.52) | SMN1; SMN2FDPSMEN1KMT2ACHRNB2 | |
| SCHEMBL15014381 | 0.74 | SMN1; SMN2 (0.52) | SMN1; SMN2FDPSMEN1KMT2ACHRNB2 | |
| SCHEMBL2835413 | 0.74 | SMN1; SMN2 (0.38) | SMN1; SMN2FDPSMEN1KMT2ACHRNB2 | |
| SCHEMBL6624504 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | claimed |
| EP-3852716-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061556-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-03-26 | — | — | WO | claimed |
| EP-2642849-A2 | USE OF AN ANTI-MOSQUITO COMPOSITION AS WASHING ADDITIVE FOR GIVING ANTI-MOSQUITO PROPERTIES TO A FABRIC | Vancini, Giorgia (IT) | 2013-10-02 | — | — | EP | claimed |
| WO-2012069908-A2 | USE OF AN ANTI-MOSQUITO COMPOSITION AS WASHING ADDITIVE FOR GIVING ANTI-MOSQUITO PROPERTIES TO A FABRIC | ELIA FRANCESCO (IT) | 2012-05-31 | — | — | WO | claimed |
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | disclosed |
| EP-1978803-B1 | INSECT REPELLENT COMPOSITION | DARLING SAMUEL T (CA) | 2016-04-06 | — | — | EP | disclosed |
| EP-2642849-A2 | USE OF AN ANTI-MOSQUITO COMPOSITION AS WASHING ADDITIVE FOR GIVING ANTI-MOSQUITO PROPERTIES TO A FABRIC | Vancini, Giorgia (IT) | 2013-10-02 | — | — | EP | disclosed |
| US-8501205-B2 | Insect repellent composition | NO MO FOUNDATION | 2013-08-06 | — | — | US | disclosed |
| WO-2012069908-A2 | USE OF AN ANTI-MOSQUITO COMPOSITION AS WASHING ADDITIVE FOR GIVING ANTI-MOSQUITO PROPERTIES TO A FABRIC | ELIA FRANCESCO (IT) | 2012-05-31 | — | — | WO | disclosed |
| US-20110183017-A1 | INSECT REPELLENT COMPOSITION | NO MO FOUNDATION | 2011-07-28 | — | — | US | disclosed |
| US-7846464-B2 | Insect repellent composition | NO MO FOUNDATION | 2010-12-07 | — | — | US | disclosed |
| EP-1978803-A2 | INSECT REPELLENT COMPOSITION | Darling, Samuel T. (CA) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007082306-A2 | INSECT REPELLENT COMPOSITION | DARLING SAMUEL T (CA) | 2007-07-19 | — | — | WO | disclosed |
| US-20070166342-A1 | INSECT REPELLENT COMPOSITION | NO MO FOUNDATION | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183017-A1 | INSECT REPELLENT COMPOSITION | TRPM8, TRPV3, LSM8 | SMN1; SMN2 3830/4885FDPS 517/4885MEN1 1113/4885 |
| US-20070166342-A1 | INSECT REPELLENT COMPOSITION | TRPM8, TRPV3, LSM8 | SMN1; SMN2 3830/4885FDPS 517/4885MEN1 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.